Suchergebnisse - "PFIZER Inc."

When a High Dividend Presents a Problem.

Quelle: Kiplinger Personal Finance. Aug2025, Vol. 79 Issue 8, p(Sp)3-(Sp)3. 1p.

Schlagwörter: *INVESTORS, *RATE of return on stocks, *BULL markets, *MERGERS & acquisitions, *CAPITAL losses, NET proceeds

Firma/Körperschaft: PFIZER Inc. 001326495 PFE

Pfizer to Acquire Metsera for up to $7.3B, Returning to Obesity Drug Race.

Autoren: Philippidis, Alex¹ (AUTHOR) APhilippidis@liebertpub.com

Quelle: GEN Biotechnology. Oct2025, Vol. 4 Issue 5, p152-154. 3p.

Schlagwörter: *ANTIOBESITY agents, *MERGERS & acquisitions, *BIOPHARMACEUTICS, *REGULATION of body weight, *THERAPEUTICS, *REGULATORY approval, *PHARMACEUTICAL industry, *SAFETY

Firma/Körperschaft: PFIZER Inc. 001326495 PFE

Fidanacogene Elaparvovec for Hemophilia B - A Multiyear Follow-up Study.

Autoren: Rasko, John EJ. Samelson-Jones, Benjamin J. George, Lindsey A. et al.

Quelle: New England Journal of Medicine. 4/17/2025, Vol. 392 Issue 15, p1508-1517. 10p.

Schlagwörter: *BLOOD coagulation factor IX, *LIVER histology, *HIV infections, *HEPATIC fibrosis, *HEMOPHILIA, *DIAGNOSTIC ultrasonic imaging

Geografische Kategorien: PADUA (Italy)

Firma/Körperschaft: PFIZER Inc. 001326495 PFE

An integrated MCDM framework for evaluating the environmental, social, and governance (ESG) sustainable business performance.

Autoren: Yu, Kerui Wu, Qun Chen, Xiaoqing et al.

Quelle: Annals of Operations Research. Nov2024, Vol. 342 Issue 1, p987-1018. 32p.

Schlagwörter: *PHARMACEUTICAL biotechnology industry, *INDUSTRIAL management, *ENVIRONMENTAL responsibility, SOFT sets, ANALYTIC hierarchy process

Firma/Körperschaft: PFIZER Inc. 001326495 PFE

BATAILLE RANGÉE.

Quelle: Biotech Finances. 11/7/2025, Issue 1134, p8-8. 2/3p.

Schlagwörter: *MERGERS & acquisitions, *INVESTORS, *PHARMACEUTICAL industry

Firma/Körperschaft: PFIZER Inc. 001326495 PFE

Pfizer to Buy Metsera for $10 Billion, Capping Bidding War.

Autoren: Langreth, Robert Davis, Michelle F. Sisco, Josh

Quelle: Bloomberg.com. 11/8/2025, pN.PAG-N.PAG. 1p.

Schlagwörter: *PHARMACEUTICAL biotechnology industry, *PHARMACEUTICAL industry, *BIDDING strategies, *GOVERNMENT regulation, *STOCKHOLDERS, *MERGERS & acquisitions, ANTIOBESITY agents

Firma/Körperschaft: PFIZER Inc. 001326495 PFE, NOVO Nordisk A/S NVO

Pfizer Sweetens Its Offer for Metsera in Bidding War Against Novo.

Autoren: Davis, Michelle F. Sisco, Josh

Quelle: Bloomberg.com. 11/7/2025, pN.PAG-N.PAG. 1p.

Schlagwörter: *PHARMACEUTICAL industry, *LEGAL compliance, *ANTITRUST law, *PHARMACEUTICAL biotechnology industry, *BIDDING strategies, *STOCK prices, ANTIOBESITY agents

Firma/Körperschaft: PFIZER Inc. 001326495 PFE

Pfizer Loses Legal Bid to Temporarily Block Novo's Metsera Offer.

Autoren: Feeley, Jef (AUTHOR)

Quelle: Bloomberg.com. 11/5/2025, pN.PAG-N.PAG. 1p.

Schlagwörter: *MERGERS & acquisitions, *PHARMACEUTICAL industry, *ANTITRUST law, LEGAL judgments

Firma/Körperschaft: PFIZER Inc. 001326495 PFE, NOVO Nordisk A/S NVO

Pfizer, Novo Boost Bids for Obesity Drugmaker Metsera in Takeover Saga.

Autoren: Muller, Madison Feeley, Jef Kresge, Naomi

Quelle: Bloomberg.com. 11/4/2025, pN.PAG-N.PAG. 1p.

Schlagwörter: *PHARMACEUTICAL biotechnology industry, *BUYOUTS, *PHARMACEUTICAL industry, *BIDDING strategies, ANTIOBESITY agents, DRUG development

Firma/Körperschaft: PFIZER Inc. 001326495 PFE, NOVO Nordisk A/S NVO

Pfizer Boosts Profit Outlook as Battle for Obesity Startup Grows.

Autoren: Muller, Madison (AUTHOR)

Quelle: Bloomberg.com. 11/4/2025, pN.PAG-N.PAG. 1p.

Schlagwörter: *PROFITABILITY, *PHARMACEUTICAL industry, *BIOTECHNOLOGY industries, *EARNINGS forecasting, REGULATION of body weight, BUDGET cuts, COMPETITION (Psychology)

Firma/Körperschaft: PFIZER Inc. 001326495 PFE

Pfizer Boosts Profit View As it Battles for Obesity Startup.

Autoren: Muller, Madison (AUTHOR)

Quelle: Bloomberg.com. 11/4/2025, pN.PAG-N.PAG. 1p.

Schlagwörter: *PHARMACEUTICAL industry, *CORPORATE profits, *PROFITABILITY, *BUSINESS enterprises, BUDGET cuts, REDUCING diets

Firma/Körperschaft: PFIZER Inc. 001326495 PFE

Pfizer Boosts Profit View While Chasing Obesity Startup Metsera.

Autoren: Muller, Madison (AUTHOR)

Quelle: Bloomberg.com. 11/4/2025, pN.PAG-N.PAG. 1p.

Schlagwörter: *PHARMACEUTICAL industry, *CORPORATE profits, *PROFITABILITY, *NEW business enterprises, *SALES statistics, *COST control, OBESITY, DRUGS

Firma/Körperschaft: PFIZER Inc. 001326495 PFE

Pfizer Sues Novo, Metsera for Second Time in Brewing Deal War.

Autoren: Muller, Madison (AUTHOR)

Quelle: Bloomberg.com. 11/3/2025, pN.PAG-N.PAG. 1p.

Schlagwörter: *ANTITRUST law, *MERGER agreements, *PHARMACEUTICAL industry, *ACTIONS & defenses (Law), REGULATION of body weight, GLUCAGON-like peptide-1 agonists

Firma/Körperschaft: PFIZER Inc. 001326495 PFE, NOVO Nordisk A/S NVO

Pfizer Sues to Block Novo Bid for Obesity Drugmaker Metsera.

Autoren: Muller, Madison Feeley, Jef

Quelle: Bloomberg.com. 10/31/2025, pN.PAG-N.PAG. 1p.

Schlagwörter: *PHARMACEUTICAL industry, *ANTITRUST law, *MERGER agreements, *BIDDING strategies, ANTIOBESITY agents

Firma/Körperschaft: PFIZER Inc. 001326495 PFE, DELAWARE. Court of Chancery , NOVO Nordisk A/S NVO

Pfizer Sues to Block Novo's Bid for Obesity Drug Startup Metsera.

Autoren: Muller, Madison Feeley, Jef

Quelle: Bloomberg.com. 10/31/2025, pN.PAG-N.PAG. 1p.

Schlagwörter: *ANTITRUST law, *PHARMACEUTICAL biotechnology industry, *MERGER agreements, *ACTIONS & defenses (Law), *PHARMACEUTICAL industry, ANTIOBESITY agents

Geografische Kategorien: UNITED States

Firma/Körperschaft: PFIZER Inc. 001326495 PFE, DELAWARE. Court of Chancery , NOVO Nordisk A/S NVO

Pfizer Gets Nod to Proceed With Metsera Deal From US Regulators.

Autoren: Muller, Madison (AUTHOR)

Quelle: Bloomberg.com. 10/31/2025, pN.PAG-N.PAG. 1p.

Schlagwörter: *MERGERS & acquisitions, *ECONOMIC competition, *ANTITRUST law, *PHARMACEUTICAL industry, *GOVERNMENT agencies, REGULATION of body weight

Geografische Kategorien: UNITED States

Firma/Körperschaft: PFIZER Inc. 001326495 PFE

Pfizer Races to Save Obesity Drugmaker Deal After Novo's Bid.

Autoren: Muller, Madison Sjolin, Sara Langreth, Robert et al.

Quelle: Bloomberg.com. 10/30/2025, pN.PAG-N.PAG. 1p.

Schlagwörter: *MERGERS & acquisitions, *PHARMACEUTICAL biotechnology industry, *LEGAL compliance, *BIDDING strategies, REDUCING diets, COMPETITION (Psychology)

Firma/Körperschaft: PFIZER Inc. 001326495 PFE, NOVO Nordisk A/S NVO

Novo, Pfizer Square Off Over Metsera in Obesity-Drug Tussle.

Autoren: Sisco, Josh Kirchfeld, Aaron Nair, Dinesh et al.

Quelle: Bloomberg.com. 10/30/2025, pN.PAG-N.PAG. 1p.

Schlagwörter: *BIOTECHNOLOGY industries, *GOVERNMENT regulation, *PHARMACEUTICAL industry, *ECONOMIC competition, APPETITE depressants, ANTIOBESITY agents

Firma/Körperschaft: NOVO Nordisk A/S NVO, PFIZER Inc. 001326495 PFE

Novo Nordisk Offers $6.5 Billion for Metsera to Challenge Pfizer.

Autoren: Sisco, Josh Carnevali, David Kirchfeld, Aaron et al.

Quelle: Bloomberg.com. 10/30/2025, pN.PAG-N.PAG. 1p.

Schlagwörter: *PAYMENT, *ECONOMIC competition, *MERGERS & acquisitions, *PHARMACEUTICAL biotechnology industry, *PHARMACEUTICAL industry, ANTIOBESITY agents

Firma/Körperschaft: NOVO Nordisk A/S NVO, PFIZER Inc. 001326495 PFE

Pfizer's Drug-Price Deal With Trump Ended Months of Deadlock.

Autoren: Zhang, Rachel Cohrs Muller, Madison Garde, Damian

Quelle: Bloomberg.com. 10/3/2025, pN.PAG-N.PAG. 1p.

Schlagwörter: *DRUG prices, *PHARMACEUTICAL industry, *HEALTH care industry, *TARIFF, *NEGOTIATION, PRESIDENTIAL administrations, DRUGS

Geografische Kategorien: UNITED States

Firma/Körperschaft: PFIZER Inc. 001326495 PFE

People: TRUMP, Donald, 1946-